Source: Planta Medica. Unidades: FCFRP, FFCLRP
Subjects: COMPOSTOS HETEROCÍCLICOS, COMPOSTOS AROMÁTICOS, POLIFENÓIS, EXTRATOS (FORMAS FARMACÊUTICAS)
ABNT
MARTINS, Júlia et al. Yangambin and Epi-yangambin isomers: new purification method from Ocotea fasciculata and first cytotoxic aspects focusing on In Vivo safety. Planta Medica, v. 86, p. 415-424, 2020Tradução . . Disponível em: https://doi.org/10.1055/a-1118-3828. Acesso em: 16 ago. 2024.APA
Martins, J., Coelho, J., Tadini, M. C., Souza, R. O. de, Figueiredo, S. A., Fonseca, M. J. V., et al. (2020). Yangambin and Epi-yangambin isomers: new purification method from Ocotea fasciculata and first cytotoxic aspects focusing on In Vivo safety. Planta Medica, 86, 415-424. doi:10.1055/a-1118-3828NLM
Martins J, Coelho J, Tadini MC, Souza RO de, Figueiredo SA, Fonseca MJV, Albuquerque NCP de, Lopes NP, Berretta AA, Marquele-Oliveira F, Oliveira ARM de. Yangambin and Epi-yangambin isomers: new purification method from Ocotea fasciculata and first cytotoxic aspects focusing on In Vivo safety [Internet]. Planta Medica. 2020 ; 86 415-424.[citado 2024 ago. 16 ] Available from: https://doi.org/10.1055/a-1118-3828Vancouver
Martins J, Coelho J, Tadini MC, Souza RO de, Figueiredo SA, Fonseca MJV, Albuquerque NCP de, Lopes NP, Berretta AA, Marquele-Oliveira F, Oliveira ARM de. Yangambin and Epi-yangambin isomers: new purification method from Ocotea fasciculata and first cytotoxic aspects focusing on In Vivo safety [Internet]. Planta Medica. 2020 ; 86 415-424.[citado 2024 ago. 16 ] Available from: https://doi.org/10.1055/a-1118-3828